Investigation of the Effectiveness of Group Voice Therapy in Children
Launched by HACETTEPE UNIVERSITY · Nov 3, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of "group voice therapy" compared to "individual voice therapy" for children diagnosed with dysphonia, which is a condition that affects the voice. The researchers want to see if practicing in a group setting helps these children improve their voice more than one-on-one sessions. The study will gather various types of information to evaluate how well each therapy works, making it a thorough investigation.
To be eligible for this trial, children must be between the ages of 7 and 11, diagnosed with vocal fold lesions, and speak Turkish as their native language. They should also be referred for treatment by a specialist. However, children with certain health issues, previous voice surgeries, or other conditions affecting their voice will not be included. Participants can expect to join therapy sessions and will be evaluated on their progress throughout the study. If you're considering this for your child, it’s a chance to help them improve their voice with professional support in a group setting.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having been diagnosed with vocal fold lesions.
- • Being referred to Hacettepe University Speech and Language Therapy Department for a diagnosis of voice disorder by Hacettepe University Ear, Nose, and Throat Department.
- • Being in the age range of 7-11.
- • Having Turkish as the native language.
- Exclusion Criteria:
- • Having a history of any upper respiratory tract infection up to two weeks before the date of data collection (it is requested to consider the last two weeks as a reference in one of the questionnaires to be filled out).
- • Having any known neurological, systemic, or endocrinological disease that affects one's voice.
- • Having undergone any surgical intervention related to the voice or received voice therapy before the research process.
- • Having a diagnosis of current hearing loss.
- • Having a neurological or psychiatric diagnosis.
- • The family or child not wanting to participate in the study.
- • Not having acquired reading and writing skills yet
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Fatma ESEN AYDINLI, Assoc. Prof.
Study Chair
Hacettepe University, Speech and Language Therapy Departmant
Meltem Çiğdem KİRAZLI, Ph.D.
Study Chair
Hacettepe University, Speech and Language Therapy Departmant
Taner Yılmaz, Prof.
Study Chair
Hacettepe University, Department of Otorhinolaryngology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported